The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
Arrang, J.-M., Garbarg, M., & Schwartz, J.-C. (1983) · Nature · doi:10.1038/302832a0 · Cited by 1,575
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
The physiology of brain histamine
Brown, R. E., Stevens, D. R., & Haas, H. L. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00039-3 · Cited by 988
Highly potent and selective ligands for histamine H3-receptors
Arrang, J.-M., Garbarg, M., Lancelo, J.-C., Lecomte, J.-M., Pollard, H., Robba, M., Schunack, W., & Schwartz, J.-C. (1987) · Nature · doi:10.1038/327117a0 · Cited by 903
(2004) · The Lancet · doi:10.1016/s0140-6736(04)16499-4 · Cited by 892 · cited 1×
“…since numerous neurotransmitter systems and brain regions are implicated (Myhrer, 2003); this is largely reflected by the significant unmet medical need that currently exists for treating the various cognitive domains affected in many of these diseases (Green et al., 2001; Courtney et al., 2004).”
BackgroundNeuropsychopharmacology : The Fifth Generation of Progress
Davis, K. L., Charney, D. S., Coyle, J. T., & Nemeroff, C. B. (2002) · Lippincott Williams & Wilkins eBooks · Cited by 747
Cloning and Functional Expression of the Human Histamine H3Receptor
Lovenberg, T. W., Roland, B. L., Wilson, S. J., Jiang, X., Pyati, J., Huvar, A., Jackson, M. R., & Erlander, M. G. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.6.1101 · Cited by 696
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Myhrer, T. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00268-0 · Cited by 472
High constitutive activity of native H3 receptors regulates histamine neurons in brain
Morisset, S., Rouleau, A., Ligneau, X., Gbahou, F., Tardivel-Lacombe, J., Stark, H., Schunack, W., Ganellin, C. R., & Arrang, J.-M. (2000) · Nature · doi:10.1038/35048583 · Cited by 461
Implications for the Neural Basis of Social Cognition for the Study of Schizophrenia
Pinkham, A. E., Penn, D. L., Perkins, D. O., & Lieberman, J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.5.815 · Cited by 451
Identification of Rat H3 Receptor Isoforms with Different Brain Expression and Signaling Properties
Drutel, G., Peitsaro, N., Karlstedt, K., Wieland, K., Smit, M. J., Timmerman, H., Panula, P., & Leurs, R. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12349-8 · Cited by 288
Hippocampal modulation of sensorimotor processes
Bast, T., & Feldon, J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00112-6 · Cited by 255
Animal models of attention-deficit hyperactivity disorder.
Davids, E., Zhang, K., Tarazi, F. I., & Baldessarini, R. J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00274-6 · Cited by 250 · cited 3×
“For example, SHRs are commonly used as a model for ADHD since they exhibit hyperactivity and impulsivity in novel environments, as well as impaired sustained and nonselective attention (Davids et al., 2003).”
BackgroundMethodNeurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor Antagonist
Ligneau, X., Lin, J.-S., Vanni-Mercier, G., Jouvet, M., Muir, J. L., Ganellin, C. R., Stark, H., Elz, S., Schunack, W., & Schwartz, J.-C. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37840-1 · Cited by 242
Blandina, P., Giorgetti, M., Bartolini, L., Cecchi, M., Timmerman, H., Leurs, R., Pepeu, G., & Giovannini, M. G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16086.x · Cited by 233
Tashiro, M., Mochizuki, H., Iwabuchi, K., Sakurada, Y., Itoh, M., Watanabe, T., & Yanai, K. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02276-2 · Cited by 178
Winslow, J. T., & Camacho, F. (1995) · Psychopharmacology · doi:10.1007/bf02245626 · Cited by 156
Witkin, J. M., & Nelson, D. L. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.05.001 · Cited by 152
Simosky, J. K., Stevens, K. E., Adler, L. E., & Freedman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1285-x · Cited by 121
Gattu, M., Terry, A. V., Pauly, J. R., & Buccafusco, J. J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00794-4 · Cited by 114
Fox, G. B., Pan, J. B., Esbenshade, T. A., Bennani, Y. L., Black, L. A., Faghih, R., Hancock, A. A., & Decker, M. W. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00379-5 · Cited by 111
Self-citationFox, G. B., Pan, J. B., Radek, R. J., Lewis, A. M., Bitner, R. S., Esbenshade, T. A., Faghih, R., Bennani, Y. L., Williams, M. J., Yao, B. B., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047241 · Cited by 100
Self-citationDecker, M. W., Bannon, A. W., Curzon, P., Gunther, K. L., Brioni, J. D., Holladay, M. W., Lin, N.-H., Li, Y., Daanen, J. F., Buccafusco, J. J., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37015-6 · Cited by 88
Self-citationA new class of potent non-imidazole H3 antagonists: 2-aminoethylbenzofurans
Cowart, M., Pratt, J. K., Stewart, A. O., Bennani, Y. L., Esbenshade, T. A., & Hancock, A. A. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.11.032 · Cited by 87
Self-citationCharacteristics of recombinantly expressed rat and human histamine H3 receptors
Wulff, B. S., Hastrup, S., & Rimvall, K. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02382-8 · Cited by 86
Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I
Gattu, M., Pauly, J. R., Boss, K. L., Summers, J. B., & Buccafusco, J. J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00793-2 · Cited by 77
Browman, K. E., Komater, V. A., Curzon, P., Rueter, L. E., Hancock, A. A., Decker, M. W., & Fox, G. B. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.11.001 · Cited by 68
Self-citationTerry, A. V., Hernandez, C. M., Buccafusco, J. J., & Gattu, M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00377-8 · Cited by 66
Bannerman, D. M., Lemaire, M., Yee, B. K., Iversen, S. D., Oswald, C., Good, M. A., & Rawlins, J. N. P. (2002) · Experimental Brain Research · doi:10.1007/s00221-001-0938-z · Cited by 63
Komater, V. A., Browman, K. E., Curzon, P., Hancock, A. A., Decker, M. W., & Fox, G. B. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1431-0 · Cited by 62
Self-citation(2000) · doi:10.1002/(sici)1098-1063(2000)10:1<47::aid-hipo5>3.0.co;2-6
Cited by
Histamine in the Nervous System
Haas, H. L., Sergeeva, O. A., & Selbach, O. (2008) · Physiological Reviews · doi:10.1152/physrev.00043.2007 · Cited by 1,228
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Realistic expectations of prepulse inhibition in translational models for schizophrenia research
Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., & Braff, D. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1072-4 · Cited by 529
L-Histidine Decarboxylase and Tourette's Syndrome
Ercan-Sencicek, A. G., Stillman, A. A., Ghosh, A. K., Bilguvar, K., O'Roak, B. J., Mason, C. E., Abbott, T., Gupta, A., King, R. A., Pauls, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907006 · Cited by 364
Neurophysiological biomarkers for drug development in schizophrenia
Javitt, D. C., Spencer, K. M., Thaker, G. K., Winterer, G., & Hajós, M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2463 · Cited by 342
Metadata
- Authors
- Fox, G. B., Esbenshade, T. A., Pan, J. B., Radek, R. J., Krueger, K. M., Yao, B. B., Browman, K. E., Buckley, M. J., Ballard, M. E., Komater, V. A., Miner, H., Zhang, M., Faghih, R., Rueter, L. E., Bitner, R. S., Drescher, K. U., Wetter, J., Marsh, K., Lemaire, M., Porsolt, R. D., Bennani, Y. L., Sullivan, J. P., Cowart, M. D., Decker, M. W., & Hancock, A. A.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 313
- Issue
- 1
- Pages
- 176-190
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1919779618
- Cited by
- 262
- References
- 33
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.